Nephrology Publications
Below are recent PubMed publications by faculty members in the Division of Nephrology in the Department of Pediatrics at Northwestern University Feinberg School of Medicine.
- Onder AM, Ansari MAY, Deng F, Grinsell MM, Patterson L, Jetton J, Fathallah-Shaykh S, Ranch D, Aviles D, Copelovitch L et al. Persistent Increase in Serum Ferritin Levels despite Converting to Permanent Vascular Access in Pediatric Hemodialysis Patients: Pediatric Nephrology Research Consortium Study. J Clin Med 2023 Jun 25;12(13). pii:4251
- Langman CB Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to "A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis"). Orphanet J Rare Dis 2023 Jun 23;18(1):162. pii:162
- Langman CB, Assimos D, Blank M, Calle J, Grauer A, Kausz A, Milliner D, Nazzal L, Smith K, Tasian G et al. End Point Considerations for Clinical Trials in Enteric Hyperoxaluria. Clin J Am Soc Nephrol 2023 Jun 21;. doi:10.2215/CJN.0000000000000234
- Corano Scheri K, Liang X, Dalal V, Le Poole IC, Varga J, Hayashida T SARA suppresses myofibroblast precursor transdifferentiation in fibrogenesis in a mouse model of scleroderma. JCI Insight 2022 Nov 08;7(21). pii:e160977
- Finer G, Maezawa Y, Ide S, Onay T, Souma T, Scott R, Liang X, Zhao X, Gadhvi G, Winter DR et al. Stromal Transcription Factor 21 Regulates Development of the Renal Stroma via Interaction with Wnt/β-Catenin Signaling. Kidney360 2022 Jul 28;3(7):1228-1241. doi:10.34067/KID.0005572021
- Wu E, Lee JY, Gelarden I, Engen RM Nondestructive versus advanced post-transplant lymphoproliferative disorder in a single-center pediatric kidney transplant population. Pediatr Transplant 2022 Jun;26(4):e14238. doi:10.1111/petr.14238
- Engen RM, Weng PL, Shih W, Patel HP, Richardson K, Dowdrick SL, Ashoor IF, Misurac J, Traum AZ, Semanik MG et al. Outcomes of granulocyte colony-stimulating factor use in pediatric kidney transplant recipients: A Pediatric Nephrology Research Consortium study. Pediatr Transplant 2022 May;26(3):e14202. doi:10.1111/petr.14202
- Hoppe B, Koch A, Cochat P, Garrelfs SF, Baum MA, Groothoff JW, Lipkin G, Coenen M, Schalk G, Amrite A et al. Safety, pharmacodynamics, and exposure-response modeling results from a first-in-human phase 1 study of nedosiran (PHYOX1) in primary hyperoxaluria. Kidney Int 2022 Mar;101(3):626-634. doi:10.1016/j.kint.2021.08.015
- Vaisbich MH, Caires Ferreira J, Price H, Young KD, Sile S, Checani G, Langman CB Cysteamine bitartrate delayed-release capsules control leukocyte cystine levels and promote statural growth and kidney health in an open-label study of treatment-naïve patients <6 years of age with nephropathic cystinosis. JIMD Rep 2022 Jan;63(1):66-79. doi:10.1002/jmd2.12260
- Ariceta G, Barrios K, Brown BD, Hoppe B, Rosskamp R, Langman CB Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria. Kidney Int Rep 2021 Apr;6(4):1088-1098. doi:10.1016/j.ekir.2021.01.029
- Bobrowski AE School and sports participation post-transplant. Pediatr Transplant 2021 Feb;25(1):e13791. doi:10.1111/petr.13791
- Kasimer RN, Langman CB Adult complications of nephropathic cystinosis: a systematic review. Pediatr Nephrol 2021 Feb;36(2):223-236. doi:10.1007/s00467-020-04487-6
- Engen RM, Jedraszko AM, Conciatori MA, Tambur AR Substituting imputation of HLA antigens for high-resolution HLA typing: Evaluation of a multiethnic population and implications for clinical decision making in transplantation. Am J Transplant 2021 Jan;21(1):344-352. doi:10.1111/ajt.16070